LETTER
Synthesis of Precursors of gem-Difluorodiols and Amino Alcohols
1019
153.82, 120.56 (dd, J = 247.0, 243.1 Hz), 74.89 (dd,
J = 34.7, 26.3 Hz), 73.63, 64.26 (dd, J = 5.0, 2.8 Hz), 54.76
(t, J = 6.7 Hz), 34.54 (dd, J = 23.5, 22.9 Hz), 27.41. 19
NMR (254 MHz, CDCl3): d = –33.90 to –35.17 (m, 1 F),
–36.78 to –37.93 (m, 1 F). FAB-MS: m/z = 239 [M+ + H].
FAB–HRMS: m/z calcd for C10H17F2O4: 239.1095; found:
239.1091.
(c) 4-[(Cyclohexyl)difluoromethyl]-1,3-dioxolan-2-one
(6): 1H NMR (270 MHz, CDCl3): d = 4.92–4.78 (m, 1 H),
4.69–4.50 (m, 2 H), 2.01–1.74 (m, 6 H), 1.31–1.24 (m, 5 H).
13C NMR (67.8 MHz, CDCl3): d = 153.61, 121.25 (dd,
J = 249.8, 243.7 Hz), 72.36 (dd, J = 41.4, 28.5 Hz), 64.02
(dd, J = 5.6, 3.9 Hz), 40.80 (t, J = 21.8 Hz), 25.76 (dd,
J = 5.6, 2.8 Hz), 25.69, 25.46 (d, J = 1.1 Hz), 25.29, 24.04
(dd, J = 4.5, 3.9 Hz). 19F NMR (254 MHz, CDCl3): d =
–54.11 (ddd, 1 F, J = 303.3, 53.6, 3.7 Hz), –59.75 (ddd, 1 F,
J = 303.3, 55.5, 16.6 Hz). FAB-MS: m/z = 221 [M+ + H].
FAB–HRMS: m/z calcd for C10H15F2O3: 221.0989; found:
221.0986.
(c) 5-[(Cyclohexyl)difluoromethyl]-3-methyloxazol-
idinone (14): 1H NMR (270 MHz, CDCl3): d = 4.73–4.59
(m, 1 H), 3.74–3.58 (m, 2 H), 2.91 (s, 3 H), 2.14–1.62 (m, 6
H), 1.33–1.13 (m, 5 H). 13C NMR (67.8 MHz, CDCl3): d =
156.69, 121.84 (dd, J = 250.1, 244.3 Hz), 69.41 (dd,
J = 39.17, 29.1 Hz), 45.79 (dd, J = 5.3, 3.4 Hz), 40.66 (t,
J = 21.8 Hz), 30.94, 29.77, 25.95 (dd, J = 6.1, 2.8 Hz),
25.84, 25.43, 24.06 (dd, J = 5.0, 3.9 Hz). 19F NMR (254
MHz, CDCl3): d = –45.35 (ddd, 1 F, J = 258.9, 20.3, 3.7 Hz),
–46.72 (ddd, 1 F, J = 258.9, 18.5, 9.2 Hz). MS: m/z = 233
[M+], 100. HRMS: m/z calcd for C11H17F2NO2: 233.1227;
found: 233.1222.
F
(d) 5-(1,1-Difluorooctyl)-3-methyloxazolidinone (15):
1H NMR (270 MHz, CDCl3): d = 4.60–4.446 (m, 1 H), 3.71–
3.60 (m, 2 H), 2.91 (s, 3 H), 2.17–1.84 (m, 2 H), 1.58–1.46
(m, 2 H), 1.37–1.25 (m, 8 H), 0.89 (t, 3 H, J = 6.8 Hz).
13C NMR (67.8 MHz, CDCl3): d = 156.65, 121.36 (dd,
J = 248.2, 239.8 Hz), 71.22 (dd, J = 40.2, 27.9 Hz), 45.81
(dd, J = 4.5, 3.4 Hz), 33.07 (dd, J = 23.5, 22.9 Hz), 31.67,
30.94, 29.25, 29.03, 22.65, 21.36 (dd, J = 5.6, 2.8 Hz),
14.14. 19F NMR (254 MHz, CDCl3): d = –35.55 to –36.72
(m, 1 F), –40.22 to 41.43 (m, 1 F). MS: m/z = 249 [M+], 149,
100. HRMS: m/z calcd for C12H21F2NO2: 249.1540; found:
249.1539.
(e) 5-[Difluoro(phenyl)methyl]-3-methyloxazolidinone
(16): 1H NMR (270 MHz, CDCl3): d = 7.55–7.42 (m, 5 H),
4.85–4.73 (m, 1 H), 3.67 (d, 2 H, J = 7.4 Hz), 2.82 (s, 3H).
13C NMR (67.8 MHz, CDCl3): d = 156.45, 132.20 (dd,
J = 25.7, 25.2 Hz), 130.72 (t, J = 1.7 Hz), 128.51, 125.69 (t,
J = 6.1 Hz), 118.65 (dd, J = 248.7, 244.3 Hz), 72.93 (dd,
J = 39.13, 32.42 Hz), 46.32 (t, J = 3.35 Hz), 30.83. 19F NMR
(254 MHz, CDCl3): d –30.25 (dd, 1 F, J = 258.9, 5.5 Hz),
–38.53 (dd, 1 F, J = 258.9, 14.8 Hz). MS: m/z = 227 [M+].
HRMS: m/z calcd for C11H11F2NO2: 227.0758; found:
227.0748.
(f) 5-[Difluoro(2-furyl)methyl]-3-methyloxazolidinone
(17): 1H NMR (270 MHz, CDCl3): d = 7.52–7.49 (m, 1 H),
6.79–6.76 (m, 1 H), 6.48–6.45 (m, 1 H), 5.04–4.91 (m, 1 H),
3.73 (d, 2 H, J = 7.6 Hz), 2.89 (s, 3 H). 13C NMR (67.8 MHz,
CDCl3): d = 156.36, 144.31 (dd, J = 2.2, 1.7 Hz), 144.45 (dd,
J = 35.8, 33.0 Hz), 114.38 (dd, J = 243.7, 240.3 Hz), 111.78
(dd, J = 3.9, 2.8 Hz), 110.78 (t, J = 1.1 Hz), 71.22 (dd,
J = 36.3, 29.6 Hz), 45.97 (t, J = 3.4 Hz), 30.87. 19F NMR
(254 MHz, CDCl3): d = –28.77 (dd, 1 F, J = 277.4, 5.5 Hz),
–39.12 (dd, 1 F, J = 277.4, 12.9 Hz). MS: m/z = 217 [M+],
117, 100. HRMS: m/z calcd for C9H9F2NO3: 217.0550;
found: 217.0551.
(d) 4-(1,1-Difluorooctyl)-1,3-dioxolan-2-one (7): 1H NMR
(270 MHz, CDCl3): d = 4.80–4.51 (m, 3 H), 2.18–1.81 (m, 2
H), 1.60–1.48 (m, 2 H), 1.39–1.23 (m, 8 H), 0.89 (t, 3 H,
J = 7.1 Hz). 13C NMR (67.8 MHz, CDCl3): d = 153.49,
120.72 (dd, J = 249.3, 241.5 Hz), 74.16 (dd, J = 40.8, 27.9
Hz), 63.96 (dd, J = 5.0, 3.4 Hz), 33.11 (dd, J = 23.5, 22.4
Hz), 31.65, 29.18, 28.98, 22.65, 21.25 (dd, J = 5.6, 2.8 Hz),
14.41. 19F NMR (254 MHz, CDCl3): d = –35.57 to –36.76
(m, 1 F), –40.22 to –41.43 (m, 1 F). MS: m/z = 236 [M+],
149. HRMS: m/z calcd for C11H18F2O3: 236.1224; found:
236.1232.
(e) 4-[Difluoro(phenyl)methyl]-1,3-dioxlan-2-one (8):
1H NMR (270 MHz, CDCl3): d = 7.56–7.45 (m, 5 H), 5.04–
4.92 (m, 1 H), 4.68–4.43 (m, 2 H). 13C NMR (67.8 MHz,
CDCl3): d = 153.32, 131.36 (dd, J = 25.2, 24.6 Hz), 131.21
(dd, J = 2.2, 1.7 Hz), 128.83, 125.59 (t, J = 6.1 Hz), 118.15
(dd, J = 249.3, 244.3 Hz), 75.88 (dd, J = 39.7, 32.4 Hz),
64.21 (t, J = 3.3 Hz). 19F NMR (254 MHz, CDCl3): d =
–30.95 (dd, 1 F, J = 262.6, 5.5 Hz), –37.90 (dd, 1 F, J =
262.6, 12.9 Hz). MS: m/z = 214 [M+], 127. HRMS: m/z calcd
for C10H8F2O3: 214.0442; found: 214.0443.
(f) 4-[Difluoro(2-furyl)methyl]-1,3-dioxolan-2-one (9):
1H NMR (270 MHz, CDCl3): d = 7.55–7.54 (m, 1 H), 6.83–
6.81 (m, 1 H), 6.51–6.50 (m, 1 H), 5.23–5.11 (m, 1 H), 4.72–
4.56 (m, 2 H). 13C NMR (67.8 MHz, CDCl3): d = 153.24,
144.97 (dd, J = 2.2, 1.7 Hz), 143.58 (dd, J = 37.4, 33.0 Hz),
113.82 (dd, J = 243.7, 240.3 Hz), 112.33 (dd, J = 3.4, 2.8
Hz), 111.00 (t, J = 1.1 Hz), 74.21 (dd, J = 37.4, 29.6 Hz),
63.94 (t, J = 3.4 Hz). 19F NMR (254 MHz, CDCl3): d =
–28.80 (dd, 1 F, J = 280.0, 5.5 Hz), –38.17 (dd, 1 F,
J = 280.0, 11.1 Hz). MS: m/z = 204 [M+], 117. HRMS:
m/z calcd for C8H6F2O4: 204.0234; found: 204.0237.
(19) (a) 5-[Difluoro(3-tetrahydrofuryl)methyl]-3-methyl-
oxazolidinone (12): 1H NMR (270 MHz, CDCl3): d = 4.67–
4.44 (m, 1 H), 4.01–3.63 (m, 6 H), 3.18–2.92 (m, 4 H), 2.22–
1.87 (m, 2 H). 19F NMR (254 MHz, CDCl3): d = –43.16 (ddd,
1 F, J = 262.6, 18.5, 12.9 Hz), –44.43 (ddd, 1 F, J = 262.4,
20.2, 3.7 Hz). MS: m/z = 222 [M+ + H]. FAB–HRMS:
m/z calcd for C9H14F2NO3: 222.0942; found: 222.0945.
(b) 5-[(3-tert-Butoxy-1,1-difluoro)propyl]-3-methyl-
oxazol-idinone (13): 1H NMR (270 MHz, CDCl3): d = 4.81–
4.67 (m, 1 H), 3.64–3.54 (m, 4 H), 2.90 (s, 3 H), 2.44–2.06
(m, 2 H), 1.19 (s, 9 H). 13C NMR (67.8 MHz, CDCl3): d =
156.82, 121.00 (dd, J = 246.5, 244.3 Hz), 73.36, 71.69 (dd,
J = 34.1, 30.2 Hz), 54.91 (dd, J = 6.7, 6.1 Hz), 46.10 (dd,
J = 4.5, 3.4 Hz), 34.37 (dd, J = 23.5, 22.9 Hz), 30.95, 27.45.
19F NMR (254 MHz, CDCl3): d = –35.48 to –37.81 (m, 2 F).
FAB–MS: m/z 252 [M+ + H]. FAB-HRMS: m/z calcd for
C11H20F2NO3: 252.1411; found: 252.1407.
(20) Electrochemical Difluorination of 5-(Phenylthio)methyl-
3-methyloxazolidinone (10):
Constant current electrolysis (40 mA/cm–2) of 10 was carried
out at platinum electrodes (2 × 2 cm2) at 40 °C in DME–
MeCN (5 mL each) containing 0.3 M Et3N·3HF using
undivided cell. After electrolysis, the supporting electrolyte
was removed by silica gel short column chromatography.
The product 11 was isolated by silica gel column chromato-
graphy (EtOAc–hexane, 1:3).
5-[Difluoro(phenylthio)methyl]-3-methyloxazolidinone
(11): 1H NMR (270 MHz, CDCl3): d = 7.63–7.60 (m, 2 H),
7.49–7.35 (m, 3 H), 4.71–4.57 (m, 1 H), 3.74–3.61 (m, 2 H),
2.88 (s, 3 H). 13C NMR (67.8 MHz, CDCl3): d = 156.09,
138.46 (dd, J = 8.9, 0.6 Hz), 136.34, 130.23, 129.11, 126.41
(dd, J = 282.3, 280.6 Hz), 71.86 (dd, J = 31.9, 27.9 Hz),
46.48 (t, J = 2.8 Hz), 30.67. 19F NMR (254 MHz, CDCl3):
d = –11.22 (dd, 1 F, J = 218.2, 9.2 Hz), –12.91 (dd, 1 F,
J = 218.2, 9.2 Hz). MS: m/z = 259 [M+], 159, 77. HRMS:
m/z calcd for C11H11F2NO2S: 259.0479; found: 259.0485.
Synlett 2006, No. 7, 1015–1020 © Thieme Stuttgart · New York